Introduction: Iron deficiency anaemia is the most common type of reversible anemia encountered during postpartum period and may lead to long-standing iron deficiency. If treated, it facilitates a healthy future for mother children. Aims Objectives: To know safety intravenous sucrose in treatment anaemia. Materials Methods: 91 postnatal women with haemoglobin between 7-10g/dl were included prosp...

OBJECTIVES Critical evaluation of iron sucrose (Malhotra, FOGSI Focus 9-11, 2009) in terms of efficacy, safety, and feasibility at rural setup for the treatment of anemia of pregnancy (Raja et al., Rawal Med J 28: 40-3, 2003) along with any reduction in blood transfusion rate at peripartum period of 37 weeks to 48 h within delivery. METHODS In a prospective cohort study conducted in Departmen...

BACKGROUND Iron deficiency is the most common single cause of anemia worldwide. Treatment consists of improved nutrition along with oral, intramuscular or intravenous iron administration. OBJECTIVES To describe the efficacy and adverse effects of intravenous iron sucrose therapy in a group of children with iron deficiency anemia who did not respond to oral iron therapy. METHODS We conducted...

OBJECTIVE To explore the safety and efficacy of intravenous (IV) iron sucrose in maintenance peritoneal dialysis (PD). DESIGN Randomized, controlled, parallel-group single-center trial. SETTING Blood Purification Center of Chaoyang, Beijing Capital University of Medical Science, China. METHODS 46 patients on PD were involved in this trial. 26 patients received IV iron sucrose (200 mg iron...

BACKGROUND The clinical need to be able to administer high doses of intravenous iron conveniently as a rapid infusion has been addressed by the recent introduction of ferric carboxymaltose and subsequently iron isomaltoside 1000. Neither requires a test dose. The maximum dose of ferric carboxymaltose is 1000 mg. The maximum dose of iron isomaltoside 1000 is based on 20 mg/kg body weight without...

To the Editor:—Preoperative anemia is a common condition among surgical patients, and it is an independent risk factor for blood transfusion in major surgery with moderate to high blood loss. Consequently, the first step to be taken in the setting of elective surgery will be the preoperative identification and evaluation of anemia early enough to implement the appropriate treatment. In this reg...

To the Editor:—Preoperative anemia is a common condition among surgical patients, and it is an independent risk factor for blood transfusion in major surgery with moderate to high blood loss. Consequently, the first step to be taken in the setting of elective surgery will be the preoperative identification and evaluation of anemia early enough to implement the appropriate treatment. In this reg...

Although iron therapy is essential to optimize use of erythropoiesis-stimulating agents (ESA), randomized, controlled trials have heretofore been unavailable to evaluate reliably the efficacy of intravenous iron as an adjuvant to ESA treatment in peritoneal dialysis (PD) patients. In a multicenter trial, patients who had anemia, PD-dependent chronic kidney disease, stable ESA therapy, and a bro...

The antigenicity of a number of different intravenous iron preparations was tested by reverse single radial immunodiffusion with antidextran antibodies. The tested products are low molecular weight iron dextran, ferumoxytol, iron isomaltoside 1000, sodium ferric gluconate, iron sucrose, and ferric carboxymaltose. Dextran-induced anaphylactic reactions have been clinically observed with low mole...